CXCL14 and idiopathic pulmonary fibrosis: Of particular note, emerging evidence has implicated CXCL14 (C-X-C chemokine ligand 14) in both fibrogenic pathways and immune dysregulation in IPF; however, its mechanistic roles and predictive value in clinical contexts remain poorly understood.